pentoxifylline has been researched along with Brain Inflammation in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Also, demyelination and glial scarring were significantly decreased in MMPI-treated mice with chronic relapsing EAE, as was central nervous system gene expression for TNF alpha and fasL." | 1.30 | Effective treatment of models of multiple sclerosis by matrix metalloproteinase inhibitors. ( Cannella, B; Clements, JM; Gearing, AJ; Liedtke, W; Mazzaccaro, RJ; Miller, KM; Raine, CS; Wucherpfennig, KW, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rosenberg, GA | 1 |
| Estrada, EY | 1 |
| Mobashery, S | 1 |
| Liedtke, W | 1 |
| Cannella, B | 1 |
| Mazzaccaro, RJ | 1 |
| Clements, JM | 1 |
| Miller, KM | 1 |
| Wucherpfennig, KW | 1 |
| Gearing, AJ | 1 |
| Raine, CS | 1 |
2 other studies available for pentoxifylline and Brain Inflammation
| Article | Year |
|---|---|
Effect of synthetic matrix metalloproteinase inhibitors on lipopolysaccharide-induced blood-brain barrier opening in rodents: Differences in response based on strains and solvents.
Topics: Animals; Benzyl Compounds; Blood-Brain Barrier; Dexamethasone; Dimethyl Sulfoxide; Disease Models, A | 2007 |
Effective treatment of models of multiple sclerosis by matrix metalloproteinase inhibitors.
Topics: Animals; Astrocytes; Autoimmune Diseases; Base Sequence; Benzyl Compounds; Chi-Square Distribution; | 1998 |